State Street Corp Verve Therapeutics, Inc. Transaction History

State Street Corp

$2.21 Trillion
Q1 2024

A detailed history of State Street Corp transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 5,097,408 shares of VERV stock, worth $26.5 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,097,408

Previous 3,866,764 31.83%

Holding current value

$26.5 Million

Previous $53.9 Million 25.59%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$10.81 - $17.96 $13.3 Million - $22.1 Million	1,230,644 Added 31.83%	5,097,408 $67.7 Million
Q4 2023 Feb 14, 2024	BUY	$8.84 - $18.7 $5.21 Million - $11 Million	589,584 Added 17.99%	3,866,764 $53.9 Million
Q3 2023 Nov 14, 2023	BUY	$11.42 - $20.82 $2.45 Million - $4.46 Million	214,148 Added 6.99%	3,277,180 $43.5 Million
Q2 2023 Aug 14, 2023	SELL	$13.34 - $19.9 $3.83 Million - $5.71 Million	-286,745 Reduced 8.56%	3,063,032 $57.4 Million
Q1 2023 May 15, 2023	SELL	$14.3 - $24.01 $16 Million - $26.9 Million	-1,121,272 Reduced 25.08%	3,349,777 $48.3 Million

Q4 2022 Feb 14, 2023	BUY	$17.85 - $40.7 $29.8 Million - $68 Million	1,671,215 Added 59.69%	4,471,049 $86.5 Million
Q3 2022 Nov 15, 2022	BUY	$15.63 - $41.49 $34.3 Million - $91.1 Million	2,194,551 Added 362.57%	2,799,834 $96.2 Million
Q2 2022 Aug 15, 2022	SELL	$11.14 - $23.17 $22.9 Million - $47.7 Million	-2,057,823 Reduced 77.27%	605,283 $9.25 Million
Q1 2022 May 16, 2022	BUY	$20.92 - $39.36 $18.8 Million - $35.4 Million	899,742 Added 51.02%	2,663,106 $60.8 Million
Q4 2021 Feb 14, 2022	BUY	$31.94 - $54.82 $48.7 Million - $83.6 Million	1,524,355 Added 637.78%	1,763,364 $65 Million
Q3 2021 Nov 15, 2021	BUY	$46.0 - $73.99 $11 Million - $17.7 Million	239,009 New	239,009 $11.2 Million

Others Institutions Holding VERV

# of Institutions

169

Shares Held

78.3M

Call Options Held

125K

Put Options Held

185K

View Full List

About Verve Therapeutics, Inc.

Ticker VERV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,942,300
Market Cap $311M
Description
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...

More about VERV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Verve Therapeutics, Inc. Transaction History